Search for: "H. LUNDBECK A/S"
Results 41 - 56
of 56
Sorted by Relevance
|
Sort by Date
4 Mar 2009, 11:00 pm
(Spicy IP) Kenya enacts Biosafety Act 2/2009 regulating activities in GMOs, establishing National Biosafety Authority (Afro-IP) US: BIO meets the press: economic health of the biotech industry; follow-on biologics; patent reform (Patent Docs) (Patent Docs) (Intellectual Property Watch) US: Obama touts generic biologics to lower drug costs (Law360) US: Genentech announces victory in Cabilly re-examination (Patent Docs) US: Federal judge rejects Scruggs family’s bid to reconsider… [read post]
22 Sep 2016, 7:10 am
Lundbeck A/S [2007] EWHC 1040 (Pat) (reported by the IPKat here):"The question of obviousness must be considered on the facts of each case. [read post]
31 Dec 2011, 1:00 pm
The deal fell apart a little more than a month after the Antitrust Division was handed an important victory when the federal district court in Washington, D.C. enjoined the proposed acquisition by H&R Block Inc. of TaxACT, a digital do-it-yourself tax-preparation software provider, at the government’s request (2011-2 Trade Cases ¶77,678). [read post]
15 Jun 2011, 4:56 am
Lundbeck A/S (IP Whiteboard) (Patentology) Focalin XR (Dexmethylphenidate) – US: Patent infringement complaint filed in response to Para IV certification: Celgene Corp. et al. v. [read post]
15 Jul 2009, 5:15 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
5 Sep 2018, 4:00 am
At one point Hochschild describes a defamation suit brought against an African-American missionary, the Rev William H Sheppard, who had worked to expose the grotesque cruelty occurring in the Congo, and the advocacy of Sheppard’s Belgian lawyer Vandervelde. [read post]
13 May 2010, 4:58 pm
Lundbeck A/S v. [read post]
15 Mar 2011, 9:22 pm
"It's against everything we stand for," said Mads Kronborg, a spokesman for H. [read post]
5 Jul 2011, 1:44 pm
He noted that:[457] “…the Opposition Division rejected the allegation that 877 was obvious over Professor Smith’s talk at the Banbury Conference. [read post]
16 Jan 2009, 7:00 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
18 Apr 2008, 2:00 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Ranbaxy and AstraZeneca reach agreement in Esomeprazole patent litigation: (SmartBrief), (IPBiz), (Spicy IP), (Profitability through Simplicity), (IP Law360), (Philip Brooks), (GenericsWeb), Cadbury loses Australian battle over exclusive use of colour purple for chocolate wrapping in its case against Darrell Lea: (Australian Trade Marks Law… [read post]
30 Mar 2022, 4:31 am
Object of the extension of patent term regime In both cases, the Full Federal Court discussed the rationale for the current extension of term regime, by reference to the comments made by the High Court in Alphapharm Pty Limited v H Lundbeck A/S [2014] HCA 42; (2014) 254 CLR 247. [read post]
11 Apr 2008, 9:00 am
No problem…: Lundbeck A/S v Generics UK Ltd & Ors: (IPKat), Exelon (Rivastigmine Tartrate) – Dr Reddy’s and Novartis settle Exelon patent dispute: (Therapeutics Daily), GeneMaker – Codon Devices, Blue Heron Biotechnology settle patent suit over gene synthesis platform: (Patent Docs), Glucophage (Metformin) – Depomed settles patent litigation against IVAX: (SmartBrief), (IP Law360), (GenericsWeb), … [read post]
19 Sep 2018, 11:28 am
”[4] The Supreme Court once reversed him for reading an “unwritten exception” into a law he didn’t like, because “[h]owever sensible” his dislike of it might have been, a “court’s task is to apply the text [of a statute], not to improve upon it. [read post]
2 May 2008, 7:00 am
: (Patent Baristas), US: How to avoid a permanent injunction: the lessons of Amgen v Hoffman-LaRoche: (Patent Docs), US: Jarvik Heart’s PTE request based on PMA shell/module submission dates flatlines; ruling on initiation of PTE ‘review period’ mirrors FDA policy for ‘fast track’ products: (FDA Law Blog) Pharma & Biotech - Products Kytril (Granisetron) – Exclusivity ‘parking’ still… [read post]
24 Nov 2018, 8:10 am
It’s not just academic knowledge in there, but there’s also practical knowledge. [read post]
